Patent Assignment
Reel/Frame 059181/0749
Assignment of Assignor's Interest
Recorded: 2022-03-07
Pages: 9
Assignors
JARJOUR, JORDAN
Executed: 2022-01-19
POGSON, MARK
Executed: 2022-01-19
LEUNG, WAI-HANG
Executed: 2022-02-10
Assignee
2SEVENTY BIO, INC.
60 BINNEY STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Property
(1)
CD33 Targeted Immunotherapies
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Intellectual Property Security Agreement
Feb 28, 2022
From: INHIBRX, INC.
To: OXFORD FINANCE LLC
Reel/Frame 059262/0780 →
Assignment of Assignor's Interest
Sep 1, 2022
From: JONES, KYLE; CRAGO, WILLIAM; SANABRIA, ANGELICA; HOLLANDS, ANDREW
To: INHIBRX, INC.
Reel/Frame 060970/0188 →
Assignment of Assignor's Interest
Apr 22, 2024
From: 2SEVENTY BIO, INC.
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 067184/0147 →
Release of Security Interest
Jun 3, 2024
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: INHIBRX, INC.
Reel/Frame 067606/0247 →
Assignment of Assignor's Interest
Jun 10, 2024
From: INHIBRX, INC.
To: INHIBRX BIOSCIENCES, INC.
Reel/Frame 067679/0338 →
Security Interest
Jan 14, 2025
From: INHIBRX BIOSCIENCES, INC.
To: OXFORD FINANCE LLC; OXFORD FINANCE LLC
Reel/Frame 069894/0045 →